Gut Microbiome
AI may detect CVD with the help of gut microbiome bacteria
AGA does not recommend probiotics for most GI conditions
Preliminary positive results seen for microbiome-based C. diff treatment
Gut bacteria linked to PAH
Link between gut microbiota, clinical outcomes generalizable among allogeneic HSCT recipients

Patterns of microbiota disruption, marked by loss of intestinal diversity and single taxa domination, appeared similar among a cohort of patients undergoing allogeneic hematopoietic stem cell transplantation across various centers and geographic areas, according to findings published in The New England Journal of Medicine.
Rise in gut microbial metabolite may elevate CHD risk

Healthy women with long-term changes in plasma trimethylamine N-oxide, a choline metabolite produced from gut microbiota, had an increased risk for CHD, which may be modified by healthy dietary patterns, according to a prospective nested case-control study published in the Journal of the American College of Cardiology.
Rebiotix completes enrollment for phase 3 trial of C. diff microbiota therapy
‘It pays’ to check the gut microbiome in patients with cirrhosis
Welcome to When in Rome: Healio’s Gastro Psych Blog

In an ongoing effort to keep up with the rapidly expanding field of psychogastroenterology and the latest updates on research, science and clinical practice advocacy, Healio Gastroenterology and Liver Disease proudly presents “When in Rome: Gastro Psych Blog.” This new resource aims to give practicing physicians more insight into the scientific and clinical intersection of gastroenterology and psychology.